Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Circulating and intratumoral macrophages in patients with hepatocellular carcinoma: correlation with therapeutic approach.

Newell P, Cottam B, Savage T, Hammill C, Wolf R, Bifulco C, Xiao HD, Crocenzi T, Hansen P, Crittenden M, Gough M.

Am J Surg. 2013 May;205(5):534-40. doi: 10.1016/j.amjsurg.2013.02.002.

PMID:
23592159
2.

Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma.

Sasaki A, Iwashita Y, Shibata K, Matsumoto T, Ohta M, Kitano S.

Surgery. 2006 Jun;139(6):755-64.

PMID:
16782430
3.

Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma.

Hiroishi K, Eguchi J, Baba T, Shimazaki T, Ishii S, Hiraide A, Sakaki M, Doi H, Uozumi S, Omori R, Matsumura T, Yanagawa T, Ito T, Imawari M.

J Gastroenterol. 2010 Apr;45(4):451-8. doi: 10.1007/s00535-009-0155-2. Epub 2009 Nov 20.

PMID:
19936602
4.

Hepatocellular carcinoma downstaging in liver transplantation.

Yu CY, Ou HY, Huang TL, Chen TY, Tsang LL, Chen CL, Cheng YF.

Transplant Proc. 2012 Mar;44(2):412-4. doi: 10.1016/j.transproceed.2012.01.043.

PMID:
22410030
5.

[Influence of microwave ablation and surgical resection of small primary hepatocellular carcinoma on hematogenous dissemination of tumor cells].

Dong BW, Wen CY, Liang P, Yu XL, Su L, Yu DJ, Xia HT.

Zhonghua Zhong Liu Za Zhi. 2006 Jan;28(1):39-42. Chinese.

PMID:
16737619
6.

Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening.

Tseng PL, Wang JH, Tung HD, Hung CH, Kee KM, Chen CH, Chang KC, Lee CM, Changchien CS, Chen PF, Tsai LS, Lu SN.

J Gastroenterol Hepatol. 2010 Aug;25(8):1426-34. doi: 10.1111/j.1440-1746.2010.06285.x.

PMID:
20659234
7.

Prognostic impact of preoperative the branched-chain amino acid to the tyrosine ratio in hepatocellular carcinoma patients after initial hepatectomy.

Mizuguchi T, Kawamoto M, Meguro M, Nakamura Y, Harada K, Kukita K, Hirata K.

J Gastrointest Surg. 2011 Aug;15(8):1433-9. doi: 10.1007/s11605-011-1566-y. Epub 2011 May 24.

PMID:
21607795
8.

Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.

Maluccio M, Covey AM, Gandhi R, Gonen M, Getrajdman GI, Brody LA, Fong Y, Jarnagin W, D'Angelica M, Blumgart L, DeMatteo R, Brown KT.

J Vasc Interv Radiol. 2005 Jul;16(7):955-61.

PMID:
16002503
9.

[Clinical significance of regulatory T cells proportion in the peripheral blood and tumor tissue in primary hepatocellular carcinoma].

Li SP, Peng QQ, Ding T, Xu J, Zhang CQ, Feng KT, Li JQ.

Zhonghua Zhong Liu Za Zhi. 2008 Jul;30(7):523-7. Chinese.

PMID:
19062720
10.

Combined therapy of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety.

Nakamoto Y, Mizukoshi E, Tsuji H, Sakai Y, Kitahara M, Arai K, Yamashita T, Yokoyama K, Mukaida N, Matsushima K, Matsui O, Kaneko S.

Clin Exp Immunol. 2007 Feb;147(2):296-305.

11.

Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities.

Ho CM, Lee PH, Shau WY, Ho MC, Wu YM, Hu RH.

Surgery. 2012 May;151(5):700-9. doi: 10.1016/j.surg.2011.12.015. Epub 2012 Jan 28.

PMID:
22284764
12.

Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.

Yin X, Zhang BH, Qiu SJ, Ren ZG, Zhou J, Chen XH, Zhou Y, Fan J.

Ann Surg Oncol. 2012 Sep;19(9):2869-76. doi: 10.1245/s10434-012-2328-0. Epub 2012 Mar 27.

PMID:
22451237
13.

[Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival].

Díaz-Sánchez A, Matilla A, Núñez O, Merino B, Peligros I, Rincón D, Salcedo M, Lo Iacono O, Vega Catalina M, Clemente G, Bañares R.

Gastroenterol Hepatol. 2010 Mar;33(3):155-64. doi: 10.1016/j.gastrohep.2009.10.001. Epub 2009 Nov 30. Spanish.

PMID:
19945770
14.

Appraisal of transarterial immunoembolization for hepatocellular carcinoma: a clinicopathologic study.

Yoshida T, Sakon M, Umeshita K, Kanai T, Miyamoto A, Takeda T, Gotoh M, Nakamura H, Wakasa K, Monden M.

J Clin Gastroenterol. 2001 Jan;32(1):59-65.

PMID:
11154173
16.

Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.

Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, Hasegawa S, Tsubouchi H; Kagoshima Liver Cancer Study Group.

J Hepatobiliary Pancreat Surg. 2009;16(3):359-66. doi: 10.1007/s00534-009-0069-7. Epub 2009 Mar 20.

PMID:
19300896
17.
18.

High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection.

Ding T, Xu J, Wang F, Shi M, Zhang Y, Li SP, Zheng L.

Hum Pathol. 2009 Mar;40(3):381-9. doi: 10.1016/j.humpath.2008.08.011. Epub 2008 Nov 7.

PMID:
18992916
19.

Radiofrequency thermal ablation for hepatocellular carcinoma stimulates autologous NK-cell response.

Zerbini A, Pilli M, Laccabue D, Pelosi G, Molinari A, Negri E, Cerioni S, Fagnoni F, Soliani P, Ferrari C, Missale G.

Gastroenterology. 2010 May;138(5):1931-42. doi: 10.1053/j.gastro.2009.12.051. Epub 2010 Jan 11.

PMID:
20060829
20.

Salvage hepatectomy for local recurrent hepatocellular carcinoma after ablation therapy.

Sugo H, Ishizaki Y, Yoshimoto J, Imamura H, Kawasaki S.

Ann Surg Oncol. 2012 Jul;19(7):2238-45. doi: 10.1245/s10434-012-2220-y.

PMID:
22302262
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk